Elevation Pharmaceuticals Obtains $30,000,000 Series B Funding

  • Feed Type
  • Date
    1/4/2012
  • Company Name
    Elevation Pharmaceuticals
  • Mailing Address
    11455 El Camino Real San Diego, CA 92130
  • Company Description
    Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. Our founding team has a successful track record starting companies and building dedicated teams to develop new drug products that improve patients’ lives.
  • Website
    http://www.elevationpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The Series B financing will allow Elevation to complete all activities sufficient to initiate Phase 3 studies by the end of 2013.
  • M&A Terms
  • Venture Investor
    Novo A/S
  • Venture Investor
    Canaan Partners
  • Venture Investor
    TPG Biotech
  • Venture Investor
    Care Capital
  • Venture Investor
    Mesa Verde Venture Partners

By posting a comment, you agree to our terms and conditions.